share_log

君聖泰醫藥-B：自願性公告股價不尋常波動

HIGHTIDE-B: VOLUNTARY ANNOUNCEMENTUNUSUAL PRICE MOVEMENTS

HKEX ·  Jun 24 07:22
Summary by Moomoo AI
君圣泰医药（HighTide Therapeutics, Inc.）於2024年6月24日發佈自願性公告，指出公司股份近期出現不尋常波動。董事會經合理查詢後確認，截至公告時間，並不知悉導致股價波動的具體原因，亦無需披露的資料或內幕消息。公司業務運營和財務狀況維持正常，無重大不利變動。公司股東及潛在投資者應謹慎處理買賣公司證券。公告由執行董事兼行政總裁劉利平博士代表董事會發出，董事會成員包括執行董事劉利平博士及于萌女士，非執行董事朱迅博士等人。
君圣泰医药（HighTide Therapeutics, Inc.）於2024年6月24日發佈自願性公告，指出公司股份近期出現不尋常波動。董事會經合理查詢後確認，截至公告時間，並不知悉導致股價波動的具體原因，亦無需披露的資料或內幕消息。公司業務運營和財務狀況維持正常，無重大不利變動。公司股東及潛在投資者應謹慎處理買賣公司證券。公告由執行董事兼行政總裁劉利平博士代表董事會發出，董事會成員包括執行董事劉利平博士及于萌女士，非執行董事朱迅博士等人。
On June 24, 2024, HighTide Therapeutics, Inc. issued a voluntary announcement stating that there has been an unusual fluctuation in the company's stock. After reasonable inquiries by the board of directors, there is no specific reason known for the fluctuation in stock price as of the time of the announcement, nor is there any information or insider news that needs to be disclosed. The company's business operation and financial condition remain normal, with no significant adverse changes. Shareholders and potential investors of the company should exercise caution in buying and selling the company's securities. The announcement was issued by Executive Director and CEO Dr. Liu Liping on behalf of the board of directors, whose members include Executive Director Dr. Liu Liping, Ms. Yu Meng, and non-executive director Dr. Zhu Xun.
On June 24, 2024, HighTide Therapeutics, Inc. issued a voluntary announcement stating that there has been an unusual fluctuation in the company's stock. After reasonable inquiries by the board of directors, there is no specific reason known for the fluctuation in stock price as of the time of the announcement, nor is there any information or insider news that needs to be disclosed. The company's business operation and financial condition remain normal, with no significant adverse changes. Shareholders and potential investors of the company should exercise caution in buying and selling the company's securities. The announcement was issued by Executive Director and CEO Dr. Liu Liping on behalf of the board of directors, whose members include Executive Director Dr. Liu Liping, Ms. Yu Meng, and non-executive director Dr. Zhu Xun.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more